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Interleukin (IL)-15 is a cytokine critical for development, maintenance, and response of T 
cells, natural killer cells, natural killer T cells, and dendritic cells. However, the identity and 
distribution of IL-15-expressing cells in lymphoid organs are not well understood. To address 
these questions, we established and analyzed IL-15-cyan fluorescent protein knock-in mice. 
We found that IL-15 was highly expressed in thymic medulla, and major histocompatibility 
complex (MHC)-IIhigh medullary thymic epithelial cells were the major source of IL-15. In 
bone marrow, IL-15 was detected primarily in VCAM-1+PDGFRβ+CD31−Sca-1− stromal 
cells, which corresponded to previously described CXCL12-abundant reticular cells. In lymph 
nodes, IL-15-expressing cells were mainly distributed in the T-cell zone and medulla. IL-15 
was expressed in some fibroblastic reticular cells and gp38−CD31− double-negative stromal 
cells in the T-cell zone. Blood endothelial cells, including all high endothelial venules, also 
expressed high IL-15 levels in lymph nodes, whereas lymphatic endothelial cells lacked IL-15 
expression. In spleen, IL-15 was expressed in VCAM-1+ stromal cells, where its expression 
increased as mice aged. Lastly, IL-15 expression in blood and lymphatic endothelial cells of 
peripheral lymphoid organs significantly increased in lipopolysaccharide-induced 
inflammation. Overall, we have identified and characterized several IL-15-expressing cells in 
primary and secondary lymphoid organs, providing a unique perspective of IL-15 niche in 
immune microenvironment. This study also suggests that some stromal cells express IL-7 and 






Interleukin (IL)-15 is a cytokine critical for development and maintenance of T lymphoid 
cells. However, the identity and distribution of IL-15-expressing cells in lymphoid organs are 
not well understood. The current study reveals by using IL-15-cyan fluorescent protein 
knock-in mice that IL-15 was expressed in subsets of thymic epithelial cells, bone marrow 
stromal cells, lymph node stromal cells, and blood endothelial cells, a unique perspective of 
IL-15 niche in immune microenvironment. Taken together with our previous observation on 
IL-7-producing cells, this study suggests that some stromal cells express IL-7 and IL-15 
differentially. Thus, the immune microenvironment appears to be consisted of functionally 




Coordinated cytokine expression by stromal cells in lymphoid organs is essential for immune 
system development and activity. Interleukin (IL)-15 is a cytokine important for 
differentiation, maintenance, and function of T cells, natural killer (NK) cells, NK T (NKT) 
cells, and dendritic cells (DCs) (1, 2). The IL-15 receptor (IL-15R) consists of a unique 
IL-15R α-chain (IL-15Rα), a β-chain (IL-2/IL-15Rβ) and a common cytokine receptor 
γ-chain (γc). IL-15 may function through trans-presentation of an IL-15/IL-15Rα complex to 
recipient cells expressing IL-2/15Rβ and γc (2, 3). Previous studies in mice lacking IL-15 or 
IL-15Rα demonstrated that IL-15 plays a critical role in development and homeostasis of 
naive CD8 T cells, memory T cells, NK cells, NKT cells, and epidermal and intestinal 
intraepithelial lymphocytes (IELs) (3-5). Nevertheless, the source of IL-15 in different 
lymphoid organs is largely unknown. 
 IL-15 mRNA is constitutively expressed in numerous organs such as placenta, 
skeletal muscle, and kidney (6). Furthermore, the expression of IL-15 is induced in DCs upon 
lipopolysaccharide (LPS) or interferon (IFN)-γ stimulation and is elevated in epithelial cells 
by infection (7, 8). Transcription factors such as nuclear factor-kappa B (NF-κB) and 
interferon regulatory factor 1 (IRF-1) reportedly function in its expression (9-11). 
IRF-1-deficient mice show impaired NK cell development due to reduced IL-15 expression in 
bone marrow stromal cells (12). Furthermore, IL-15 expression is regulated at the 
translational and posttranslational levels (1). Because IL-15 protein is secreted at low levels, it 
is barely detectable by antibodies, even after stimulation. 
 To overcome these difficulties, two independent laboratories constructed IL-15 
reporter mice by introducing bacterial artificial chromosome (BAC) transgenes harboring 
genes encoding fluorescent reporters controlled by the IL-15 promoter (13, 14). Using these 
mice, they detected significant fluorescence signals in CD8+ conventional DCs (cDCs) and 
macrophages, expression augmented by vesicular stomatitis virus stimulation. However, 
reporter-expressing cells have not been reported in stromal cell populations. Such an inability 
to detect IL-15-expressing cells could be explained if BAC transgenes lacked regulatory 
elements required for IL-15 expression in stromal cells. Therefore, the distribution of 
IL-15-expressing cells is not completely characterized. 
 Here, to characterize the IL-15-expressing cells in vivo, we established a novel 
reporter mouse line, in which an enhanced cyan fluorescent protein (CFP) cDNA was inserted 
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into the endogenous IL-15 locus. Using the IL-15-CFP knock-in mice, we revealed 
IL-15-expressing stromal cells showing a distinct distribution in primary and secondary 
lymphoid organs. Moreover, we demonstrated age-dependent augmentation and LPS-induced 
enhancement of IL-15 expression in some stromal cells. Thus, we have identified a new 
category of IL-15-expressing cells using an IL-15-CFP knock-in mouse that serves as a 
sensitive tool to dissect IL-15 niche in vivo. Taken together with previous observations of 
IL-7-green fluorescent protein (GFP) knock-in mice, we suggest that IL-7 and IL-15 are 




Generation of IL-15-CFP Knock-in Mice 
To determine the distribution of IL-15-producing cells in vivo, we generated IL-15-CFP 
knock-in mice. CFP cDNA and a neomycin resistance cassette were inserted at the ATG 
codon of the third IL-15 exon by homologous recombination (Fig. S1). The neomycin cassette 
was then removed by Cre recombinase. We analyzed IL-15-CFP heterozygotes in all 
experiments. IL-15-CFP mice showed normal development of lymphoid organs. 
 
IL-15 Is Highly Expressed in Thymic Medulla 
Previous reports demonstrated significantly reduced numbers of thymic NK and NKT cells in 
IL-15 knockout mice, although the source of IL-15 had not been identified (5). To detect an 
IL-15 signal directly, we performed multi-photon microscopy using thymus freshly excised 
from IL-15-CFP mice and littermate controls. CFP signals were clearly detected in thymus, 
and many were clustered in distinct areas (Fig. S2A). 
 To identify IL-15-expressing cells in thymus, we performed immunohistochemistry 
using an anti-GFP antibody combined with staining of cortical and medullary thymic 
epithelial cells (cTECs and mTECs) with anti-Ly51 and anti-EpCAM antibodies, respectively. 
Surprisingly, IL-15-expressing cells were predominantly localized in the thymic medulla and 
displayed EpCAM staining, while a few were scattered in corticomedullary junction and 
co-expressed Ly51 marker (Fig. 1A). Furthermore, many mTECs expressing IL-15 also 
expressed high levels of major histocompatibility complex (MHC)-II in thymic medulla (Fig. 
1B). We also stained blood endothelial cells (BECs) and pericytes with anti-CD31 and 
anti-PDGFRβ antibodies, respectively, and found that most BECs and some pericytes 
expressed IL-15, primarily in the thymic medulla (Fig. 1C). To discriminate between 
hematopoetic and non-hematopoietic cells, we stained DCs and macrophages with 
anti-CD11c and anti-CD11b antibodies as well as anti-CD31 and anti-GFP antibodies. In 
contrast to IL-15-expressing CD31+ BECs, DCs and macrophages in thymus lacked IL-15 
expression (Fig. S2B). These results suggest that MHC-IIhigh mTECs were the major source of 
IL-15 in the thymus. 
 
IL-15 Expression in Bone Marrow Stromal Cells 
IL-15 transpresentation functions in development and homeostasis of NK, NKT, and memory 
CD8+ T cells in bone marrow (15, 16). To monitor IL-15 signals, we carried out multi-photon 
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microscopy with calvaria of IL-15-CFP mice and littermate controls in vivo. We found that 
some IL-15-expressing cells were distributed around small blood vessels in bone marrow (Fig. 
S2C). To further characterize IL-15-expressing cells, we stained cryosections of bone marrow 
with anti-VCAM-1 (for bone marrow stromal cells) and anti-GFP antibodies. 
IL-15-expressing cells were scattered throughout the entire bone marrow (Fig. 1D). Most 
IL-15 signals colocalized with VCAM-1+ stromal cells. Furthermore, numerous VCAM-1+ 
stromal cells exhibiting an extended triangular morphology and located adjacent to blood 
vessels expressed high levels of IL-15 (Fig. 1D, Left). We also performed multi-photon 
microscopy with calvaria of IL-15-CFP/IL-7-GFP double knock-in mice in vivo. We found 
that most IL-15-expressing cells overlapped with IL-7-expressing cells, while some 
IL-7-expressing cells lacked IL-15 expression in bone marrow (Fig. S2D). 
 
Differential IL-15 Expression in Thymic Stromal Populations 
We next characterized the nature of IL-15-expressing cells in thymus by flow cytometry using 
anti-GFP antibody. We carried out flow cytometry of CD45−Ter119− thymic stromal cells. 
TECs were separated into three subsets with anti-Ly51, anti-EpCAM, and anti-MHC-II 
antibodies (Fig. 2A). MHC-IIhigh mTECs expressed high IL-15 levels, whereas a small fraction 
of MHC-IIlow mTECs and cTECs expressed low levels of IL-15 (Fig. 2B). Consistent with 
data derived from immunohistochemistry and flow cytometry, endogenous IL-15 transcript 
levels were significantly higher in MHC-IIhigh mTECs than in MHC-IIlow mTECs and cTECs 
sorted from wild-type mice (Fig. 2C). We also separated EpCAM− non-epithelial stromal cells 
into CD31+ BECs and EpCAM−CD31−PDGFRβ+ stromal cells, the last of which contained 
pericytes (Fig. 2D). Approximately 60-70% BECs and a subset of EpCAM−CD31−PDGFRβ+ 
stromal cells expressed IL-15 (Fig. 2E). Overall, these results demonstrate that MHC-IIhigh 
mTECs are the major source of IL-15, while other TECs, BECs, and some pericytes express 
lower IL-15 levels. 
 
IL-15 Is Highly Expressed in a Fraction of Mesenchymal Stromal Cells in Bone Marrow 
The major source of IL-15 in bone marrow is reportedly a distinctive stromal cell population 
known as CXCL12-abundant reticular (CAR) cells (17). We separated CD45−Ter119− bone 
marrow stromal cells into CD31+Sca-1+ BECs, CD31−Sca-1+ cells, and 
VCAM-1+PDGFRβlowCD31−Sca-1− and VCAM-1+PDGFRβhighCD31−Sca-1− stromal cells 
(Fig. 2F), and assessed CFP expression. More than 60% of 
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VCAM-1+PDGFRβhighCD31−Sca-1− CAR cells expressed high IL-15 levels, whereas a subset 
of CAR cells lacked IL-15 expression. In addition, less than 10% of 
VCAM-1+PDGFRβlowCD31−Sca-1− stromal cells expressed low levels of IL-15, and BECs 
and CD31−Sca-1+ stromal cells in bone marrow completely lacked IL-15 expression (Fig. 2G). 
IL-15 and CXCL12 transcripts were analyzed in BECs and in CFP+ and CFP− CAR cells 
sorted from IL-15-CFP mice using quantitative RT-PCR. IL-15 transcript levels were 
significantly greater in the CFP+ fraction of CAR cells than in CFP− CAR cells and BECs (Fig. 
2H). Strikingly, CXCL12 transcripts were highly expressed in CFP+ and CFP− CAR cells 
compared to BECs (Fig. 2I). These results indicate that IL-15 is expressed primarily in a 
subset of CAR cells. 
 
IL-15 Is Expressed in the T-cell Zone and Medulla of Lymph Nodes 
Apart from its role in primary lymphoid organs, IL-15 is also critical for homeostasis of T, 
NK, and NKT cells in the periphery (4, 5). Thus, we examined peripheral lymph nodes by 
immunohistochemistry with anti-gp38 (for fibroblastic reticular cells: FRCs), anti-CD11c (for 
DCs), and anti-CD3 (for T-cells) antibodies, as well as using an anti-GFP antibody. 
Interestingly, IL-15-expressing cells were predominant in the T-cell zone and medulla but 
absent from B cell-rich follicles in axillary, cervical, and inguinal lymph nodes (Fig. 3 A and 
B). In contrast, only a few IL-15-expressing cells were present in the T-cell zone of 
mesenteric lymph nodes (Fig. 3B). 
 As stromal cells of the lymph node can be divided into four fractions with anti-gp38 
and anti-CD31 antibodies (18, 19), we carried out flow cytometry of CD45−Ter119− lymph 
node stromal cells and divided them into gp38+CD31− FRCs, gp38+CD31+ lymphatic 
endothelial cells (LECs), gp38−CD31+ BECs, and double-negative stromal cells (DNSCs) 
(Fig. 3C). IL-15 was expressed in 40-50% of FRCs but completely absent from LECs. 
Importantly, more than 80% of BECs expressed significantly high levels of IL-15 in 
peripheral lymph nodes (Fig. 3D, Upper). In contrast, whereas BECs expressed high levels of 
IL-15, only a limited number of FRCs expressed very low levels of IL-15 in mesenteric 
lymph nodes (Fig. 3D, Lower). Moreover, some DNSCs in the T-cell zone expressed IL-15 in 
peripheral lymph nodes (Fig. 3D, Upper). 
 We next performed immunohistochemistry with sections of lymph node tissue using 
anti-gp38 and anti-CD31 antibodies. Consistent with the flow cytometry results, BECs and 
FRCs but not LECs expressed IL-15 in lymph nodes (Fig. 3E). All high endothelial venules 
(HEVs) also expressed high IL-15 levels, whereas only about a half of non-HEV BECs 
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expressed IL-15 (Fig. 3F). Some DNSCs in T-cell zones expressed high IL-15 levels (Fig. 
3G). We also confirmed IL-15 expression in some hematopoietic subsets such as DCs and 
macrophages by staining with anti-CD31 and anti-CD11c or anti-CD11b antibodies as well as 
anti-GFP antibody. We found some DCs and macrophages adjacent to IL-15-expressing 
stromal cells were CFP+ in lymph nodes (Fig. S3 A and B). Additionally, the frequency of 
DCs and macrophages in all IL-15-expressing cells in T-cell zone was less than 10%. Overall, 
these results demonstrate that a variety of stromal cells in the T-cell zone and medulla express 
IL-15 in lymph nodes and that all HEVs show significant IL-15 expression. 
 
Age-dependent IL-15 Expression in Splenic Stromal Cells 
To investigate IL-15-expressing cells in spleen, we analyzed sections of spleen tissue using 
anti-VCAM-1 (for splenic stromal cells) and anti-CD3 antibodies as well as anti-GFP 
antibody. CFP signals were very weak in young (1 month old) mice but nonetheless 
detectable in VCAM-1+ stromal cells within the T-cell zone and red pulp (Fig. 4A). Consistent 
with previous reports that IL-15 is expressed by DCs in spleen, we found that CD8+ cDCs 
were the major source of IL-15 in the DC fraction, whereas plasmacytoid DCs (pDCs) 
completely lacked IL-15 expression (Fig. S3 C and D). 
 Because the number of NKT and CD8 T cells increases as mice age (20-22), we 
asked whether IL-15 expression in spleen also changes with aging. We found that IL-15 
expression increased in aging (10-month-old) mice compared to young mice (Fig. 4A). To 
characterize IL-15-expressing cells in aging spleen, we carried out flow cytometry of 
CD45−Ter119− spleen stromal cells with anti-VCAM-1 and anti-CD31 antibodies (Fig. 4B). 
We observed IL-15 expression in VCAM-1+CD31− stromal cells, and the number of CFP+ 
stromal cells as well as CFP levels increased with age, whereas BECs did not express IL-15 at 
any time point (Fig. 4 C and D). In contrast, IL-15 expression remained unchanged in stromal 
cell populations of aging lymph nodes (Fig. S4). These results suggest that IL-15 expression 
in splenic stromal cells is up-regulated in an age-dependent manner. 
 
Endothelial Cells in the Lamina Propria of the Small Intestine Strongly Express IL-15 
Several studies indicate that IL-15 produced by intestinal epithelial cells (IECs) supports 
maintenance of IELs in the small intestine (3, 23). Therefore, we analyzed small intestine 
tissue sections by immunohistochemistry with anti-EpCAM and anti-CD31 antibodies. 
Although detection of IL-15 mRNA in IECs has been reported, we observed extremely weak 
CFP signals only in a few epithelial cells. In contrast, we found some CFP+ cells in lamina 
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propria, and many were co-stained with anti-CD31 antibody (Fig. 4E). Thus, endothelial cells 
in the lamina propria may express higher IL-15 than IECs in small intestine. 
 
IL-15 Expression Increases Following LPS-induced Inflammation 
IL-15 plays a regulatory role in DCs in inflammation induced by LPS stimulation (7, 24). 
Thus, we analyzed IL-15 expression in DCs after LPS stimulation. IL-15 expression was 
slightly up-regulated in cDCs after stimulation (Fig. S5). To analyze IL-15-expressing stromal 
cells under inflammatory conditions, we injected IL-15-CFP knock-in mice with LPS and 
assessed potential changes in IL-15 expression 3 days later. In lymph nodes, the number of 
IL-15-expressing cells significantly increased (Figure 5A). Surprisingly, induction of IL-15 
expression was seen in gp38+CD31+ LECs after LPS stimulation (Fig. 5A). Furthermore, we 
gated out hematopoietic cells with anti-CD45, anti-CD11c, and anti-CD11b antibodies by 
flow cytometry (Fig. S6), and evaluated the alteration of IL-15 expression in stromal cell 
subsets. In lymph nodes, the level of IL-15 expression by BECs significantly increased, and 
the proportion of IL-15high BECs also increased by 2-fold. IL-15 expression in FRCs and 
DNSCs was unchanged after LPS administration (Fig. 5 B and C). In spleen, 
VCAM-1+CD31− stromal cells expressed slightly higher IL-15 after stimulation. Notably, 
IL-15 was slightly induced in BECs by LPS stimulation (Fig. 5 D and E). Overall, these 
results demonstrate that IL-15 expression in BECs and LECs of peripheral lymphoid organs 
significantly increases in the presence of LPS-induced inflammation. 
 
IL-15 Expression in Other Organs 
As IL-15 mRNA was detected in various organs such as lung, liver, kidney, heart, and 
skeletal muscle (1, 6), we performed immunohistochemistry of these organs in IL-15-CFP 
knock-in mice. We did not detect CFP signals in lung, liver, kidney, and skeletal muscle at 
steady state. However, we found that endocardium of heart expressed IL-15 (Fig. S7A). 
Furthermore, we observed that liver macrophages expressed high levels of IL-15 after LPS 




The cytokine IL-15 plays critical roles in development, maintenance, and response of naive 
CD8 T cells, memory T cells, NK cells, NKT cells, and IELs. Although IL-15 expression by 
DCs has been reported, the distribution of IL-15-expressing cells in the stromal cell fraction 
remains relatively uncharacterized in part due to low protein expression. Recently, others 
constructed two BAC transgenic mouse lines to track IL-15-expressing cells (13, 14). 
However, in those mice, detection of IL-15-expressing cells was limited to hematopoietic 
subsets, possibly because the BAC constructs lack regulatory elements necessary for stromal 
cell IL-15 expression. We constructed an IL-15-CFP knock-in mouse and observed a variety 
of IL-15-expressing stromal cells in lymphoid organs, suggesting that IL-15 expression is 
regulated differently between lymphoid and stromal cells. 
 MHC-IIhigh mTECs may be the site for expansion of CD8 T cells and NKT cells in 
the thymus. IL-7 and other γc cytokines reportedly play a role in their expansion (25, 26). We 
found that MHC-IIhigh mTECs produce high levels of IL-15. As IL-15 is a key regulator of 
development and homeostasis of CD8 T and NKT cells in thymus, the difference in IL-15 
expression that we observed between medulla and cortex suggests that a distinct IL-15 niche 
for CD8 T and NKT cells exists in thymic medulla. In that tissue, MHC-IIhigh mTECs may 
provide a site for negative selection and maintenance of CD8 T and NKT cells. 
 CAR cells are the major source of IL-15 in bone marrow. We observed 
IL-15-expressing cells scattered in the entire bone marrow, many of them 
VCAM-1+PDGFRβ+CD31−Sca-1− CAR cells. These results are consistent with a report that 
CAR cells express high levels of IL-15 mRNA (27) and suggest that IL-15-expressing cells 
support development and homeostasis of memory T, NK, and NKT cells. Interestingly, we 
identified IL-15+ and IL-15− subsets of CAR cells. 
 IL-15 is critical for proliferation and maintenance of memory T cells, NK cells, NKT 
cells, and IELs. In lymph nodes, IL-15-expressing cells were localized in the T-cell zone and 
medulla. We found that some FRCs and DNSCs express IL-15. These stromal cells may 
function in homeostasis of memory T and NKT cells. One question to be addressed in future 
studies is whether IL-15-expressing FRCs and DNSCs have equivalent functions. 
 In spleen, we identified IL-15-expressing VCAM-1+CD31− stromal cells in the T-cell 
zone and red pulp. Interestingly, IL-15 expression by splenic stromal cells increased with age. 
The numbers of memory phenotype CD8 T and NKT cells reportedly increase in the aging 
spleen (20, 21). Therefore, IL-15-expressing stromal cells may serve as a splenic 
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microenvironment supporting expansion of memory CD8 T and NKT cells. 
 BECs express IL-15 at high levels. We showed that BECs in thymus, lymph nodes, 
and Peyer’s patches express IL-15 at high levels. Remarkably, HEVs in lymph nodes express 
high IL-15 levels. IL-15 is reportedly important for interaction of T-cells with BECs in vitro 
(28, 29). Our results suggest that IL-15 produced by BECs may function in adhesion and 
migration of lymphocytes in lymphoid organs. 
 Inflammation induces IL-15 in multiple cell types. LPS and inflammatory cytokines 
induce IL-15 in DCs (7). In this study, we showed that LPS also induces IL-15 expression in 
the stromal cell fraction. LPS-induced inflammation greatly increased IL-15 expression in 
BECs and LECs, whereas expression in other stromal cells was only slightly increased or 
unchanged. These results are consistent with reports that TLR4 is expressed in BECs and 
LECs (30, 31). IL-15 reportedly induces hyaluronate, which functions in lymphocyte rolling 
in blood vessels (28). Thus, autocrine secretion of IL-15 by BECs might induce hyaluronate 
and enhance extravasation of T-cells and DCs in inflammation. Moreover, because DCs 
express IL-15Rα and help lymphocytes enter into lymph nodes through HEVs (32, 33), IL-15 
produced by BECs and LECs might activate DCs in inflammation. Thus, IL-15 induction by 
BECs and LECs may alter lymphocyte migration in inflammation. 
 IL-7 and IL-15 are differentially expressed in some lymphoid organs (Table S1). We 
previously reported the distribution of IL-7-producing cells using IL-7-GFP knock-in mice 
(34). In thymus, IL-15 is highly expressed in MHC-IIhi mTECs, whereas IL-7 is broadly 
expressed in both cTECs and mTECs. Additionally, BECs in thymus expressed IL-15 but not 
IL-7. In bone marrow, IL-15 and IL-7 are expressed by VCAM-1+CD31− stromal cells, and 
especially IL-15 is mainly expressed in a subset of VCAM-1+PDGFRβ+CD31−Sca-1− CAR 
cells. However, IL-15 is not expressed in VCAM-1+CD31+ stromal cells and PDGFRα+Sca-1+ 
stromal cells including mesenchymal stem cells and endosteal cells (35, 36), which express 
high levels of IL-7. Because most IL-15-expressing cells were contained in IL-7-expressing 
cell population in bone marrow of IL-15-CFP/IL-7-GFP double knock-in mice, some CAR 
cells seem to express IL-7. IL-15 is expressed in BECs, whereas IL-7 is expressed in LECs of 
lymph nodes and the intestinal lamina propria. Although FRCs express both IL-7 and IL-15 in 
lymph nodes, it is not clear whether IL-7- and IL-15-producing cells overlap or constitute 
different populations, due to undetectable levels of direct CFP and GFP fluorescence in 
secondary lymphoid organs of IL-15-CFP/IL-7-GFP double knock-in mice. Differential 
expression of IL-7 and IL-15 suggests that the immune microenvironment is organized, at 
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least in part, as a mosaic of different cytokine-producing stromal populations, an arrangement 
that may facilitate efficient maintenance and responsiveness of lymphoid cells. 
 In conclusion, we successfully identified and characterized IL-15-expressing cells in 
primary and secondary lymphoid organs using IL-15-CFP knock-in mice. Our study provides 
a perspective of the IL-15 niche in the immune microenvironment and will encourage analysis 
of the local functions of IL-15 produced by stromal cells in various lymphoid organs. Our 
study also indicates that IL-7 and IL-15 are differentially expressed by stromal cells and 
suggests a classification of functionally different stromal cell subsets.  
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Materials and Methods 
 
Mice. 
Generation of IL-15-CFP knock-in mice is described in SI Materials and Methods. IL-7-GFP 
knock-in mice were reported previously (34). All mice were maintained under specific 
pathogen-free conditions in the Experimental Research Center for Infectious Diseases in the 
Institute for Virus Research, Kyoto University. All mouse protocols were approved by the 
Animal Research Committee at the Institute for Virus Research, Kyoto University. 
 
Isolation of Stromal Cells. 
Tissues were dissected into small pieces and incubated in 1 ml of RPMI 1640 medium 
mixture containing 1.25 mg/ml collagenase D (Roche), 0.8 mg/ml Dispase (Roche), and 0.1 
mg/ml DNase (Roche) at 37oC for 45 min with constant shaking. In the case of lymph nodes 
and spleen, the mixture also contained 0.2 mg/ml collagenase P (Roche). The cell suspension 
was gently passed twice through a 24-gauge needle and washed with PBS containing 0.5% 
BSA and 2 mM EDTA (MACS buffer). Hematopoietic cells were depleted with anti-CD45 
and anti-Ter119 microbeads and an LD column (Miltenyi Biotec). 
 
Flow Cytometry. 
Cells were stained with fluorescent dye- or biotin-conjugated antibodies described in SI 
Materials and Methods. Hematopoietic cells were gated out with anti-CD45 and Ter119 
antibodies. Intracellular staining was performed using FIX & PERM Cell Fixation and 
Permeabilization reagents (Invitrogen). An anti-GFP antibody (Invitrogen) with 
cross-reactivity to CFP was used to detect CFP. Stained cells were acquired with a FACS 
Canto II flow cytometer (BD Biosciences) and analyzed using FlowJo software (Tree Star). 
Cell sorting was performed using a FACS Aria II cell sorter (BD Biosciences). 
 
Immunohistochemistry. 
Tissue sections were prepared and analyzed as described (34). After blocking, samples were 
incubated with the fluorescent dye- or biotin-conjugated antibodies described in SI Materials 
and Methods and then mounted with PermaFluor (Shandon). Bone marrow sections were 
prepared using the film method (37). Confocal microscopy was performed with TSC-SP5 and 




Total RNA was extracted from sorted cells using Sepasol reagent (Nacalai) and from fixed 
samples using an RNeasy FFPE kit (Qiagen). cDNA was synthesized with random primers 
and amplified in duplicate by QuantiTect SYBR Green PCR kit (Qiagen) with ROX 
(Invitrogen) using an ABI 7500 sequence detector (Applied Biosystems). PCR efficiency was 
normalized using cDNA of whole thymus or bone marrow from wild-type mice. Primer 
sequences were as follows: IL-15 forward, 5’-GTGACTTTCATCCCAGTTGC-3’ and 
5’-TTCCTTGCAGCCAGATTCTG-3’; CXCL12, 5’-GAGCCAACGTCAAGCATCTG-3’ 
and 5’- CGGGTCAATGCACACTTGTC-3’. 
 
LPS Treatment In Vivo. 
Mice were injected intravenously with 30 µg of LPS from Escherichia coli (Sigma) in 200 µl 
PBS 3 days before the analysis as described previously (7, 38). 
 
Statistics. 
An unpaired two-tailed Student’s t-test was used for all statistical analysis. Asterisks in all 
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Figure 1. Distribution of IL-15-expressing cells in primary lymphoid organs. 
Immunohistochemical analysis of thymus (A–C) and bone marrow (D) of 6- to 10-week-old 
IL-15-CFP knock-in mice (IL-15CFP/+) and control wild-type littermates (WT). CFP signals 
were detected with anti-GFP antibody. (A and B) mTECs and cTECs were stained with 
anti-EpCAM (red) and anti-Ly51 (blue) antibodies, respectively. Most CFP+ cells (green) in 
medulla display the mTEC marker and these double stained (red and green overlap) cells 
appear yellow, while a few cTECs at the cortico-medullary junction also express IL-15 (A, 
arrowheads). CFP+ mTECs were co-stained with anti-MHC-II antibody and these triple 
stained (red, green and blue overlap) cells appear white (B, arrowheads). M, medulla; C, 
cortex. (C) BECs and pericytes were stained with anti-CD31 (green) and anti-PDGFRβ (light 
blue) antibodies, respectively. BECs and pericytes (arrows) colocalized with CFP+ cells (red). 
These double stained cells appear yellow and white, respectively. (D) VCAM-1+ stromal cells 
(blue), which are primarily adjacent to blood vessels (arrows), express high levels of CFP 
(red). Data represent three independent experiments with similar results. Scale bar, 100 µm. 
 
Figure 2. Characterization of IL-15-expressing cells in thymus and bone marrow. 
Flow cytometric analysis of IL-15-expressing cells in thymus (A, B, D, and E) and bone 
marrow (F and G). Stromal cells were isolated from 6- to 10-week-old IL-15-CFP knock-in 
mice (IL-15CFP/+) and control wild-type littermates (WT). CFP signals were detected by 
cytoplasmic staining with anti-GFP antibody. (A and B) Isolation and CFP expression of TEC 
subsets. (C) IL-15 mRNA levels were measured by real-time RT-PCR in TEC subsets isolated 
as shown in (A). cTECs (C), MHC-IIlow mTECs (Mlo), MHC-IIhigh mTECs (Mhi), and 
EpCAM− non-TECs (N). T-cells (T) from IL-15-CFP knock-in mice served as a negative 
control. Values are the mean ± SEM of duplicate data points. Data represent three 
independent experiments with similar results. (D and E) Isolation and CFP expression of 
thymic stromal cells. (F and G) Isolation and CFP expression of bone marrow stromal cells. 
BEC (CD31+Sca-1+). (H and I) IL-15 and CXCL12 mRNA levels were measured by real-time 
RT-PCR in bone marrow stromal cells isolated as shown in (G). CFP+ and CFP– fractions of 
VCAM-1+PDGFRβhighCD31–Sca-1– stromal cells (CFP+ and CFP–, respectively). Values are 




Figure 3. Characterization of IL-15-expressing cells in lymph nodes. 
CFP expression in lymph nodes of 8- to 10-week-old IL-15-CFP knock-in mice (IL-15CFP/+) 
and control wild-type littermates (WT). CFP signals were detected with an anti-GFP antibody. 
(A and B) CFP+ cells in axillary or inguinal lymph nodes (pLN, A and upper panels in B) and 
mesenteric lymph nodes (mLN, lower panels in B). T, T-cell zone; B, B-cell zone; M, 
medulla. (C and D) Isolation and CFP expression of lymph node stromal cell fractions. 
CD45−Ter119− stromal cells were isolated from axillary, cervical, or inguinal lymph nodes 
(pLN, upper panel) and mesenteric lymph nodes (mLN, lower panel) and divided into FRC 
(gp38+CD31−), DNSC (gp38−CD31−), LEC (gp38+CD31+), and BEC (gp38−CD31+) fractions 
with anti-gp38 and anti-CD31 antibodies. (E) CFP expression in stromal cells of the T-cell 
zone. CFP+ FRCs (red and green overlap) and BECs (red and blue overlap) appear yellow and 
magenta, respectively. LECs (green and blue overlap) appear turquoise blue. (F) CFP 
expression in CD31+ BECs, including HEVs. CFP+ BECs (red and green overlap) appear 
yellow. (G) CFP expression in some DNSCs (arrowheads, single red). Data represent three 
independent experiments with similar results. Scale bar, 100 µm. 
 
Figure 4. Characterization of IL-15-expressing cells in spleen and small intestine. 
CFP expression in spleen and small intestine of IL-15-CFP knock-in mice (IL-15CFP/+) and 
control wild-type littermates (WT). CFP signals were detected with an anti-CFP antibody. (A) 
CFP+ cells in spleen. Stromal cells and T-cells were stained with anti-VCAM-1 and anti-CD3 
antibodies, respectively. CFP+ stromal cells (red and green overlap) appear yellow. (B and C) 
Age-dependent IL-15 expression in splenic stromal cells. Spleen cells from IL-15-CFP 
knock-in mice and control wild-type littermates were stained with anti-CD45, anti-VCAM-1, 
and anti-CD31 antibodies. BEC (CD31+VCAM-1low). (D) Percentages of CFP+ cells in 
stromal cells and BECs of IL-15-CFP knock-in spleen. Values are the mean ± SEM from 
three independent experiments. (E) IECs and BECs were stained with anti-EpCAM and 
anti-CD31 antibodies. CFP+ IECs (red and green overlap) and BECs (red and blue overlap) 
appear yellow and magenta, respectively. BECs express high levels of IL-15 (arrowheads), 
whereas IECs express low levels of IL-15. V, villi; P, Peyer’s patch. Scale bar, 100 µm. 
 
Figure 5. LPS stimulation induces IL-15 expression in BECs and LECs of peripheral 
lymphoid organs. 
Ten-week-old IL-15-CFP knock-in mice (IL-15CFP/+) and control wild-type (WT) littermates 
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were injected with LPS. CFP signals were detected with an anti-GFP antibody. (A) 
Immunohistochemical analysis of lymph nodes 3 days after injection of PBS (control, upper 
panels) or LPS (lower panels). FRCs and LECs (arrowheads) were stained with anti-gp38 and 
anti-CD31 antibodies, respectively. CFP+ FRCs (red and green overlap) and BECs (red and 
blue overlap) appear yellow and magenta, respectively. CFP+ and CFP− LECs appear white 
and turquoise blue, respectively. T, T-cell zone. Scale bar, 40 µm. (B) Flow cytometric 
analysis of lymph nodes 3 days after injection of PBS (control, upper panels) or LPS (lower 
panels). Hematopietic cells were gated out with anti-CD45, anti-CD11c, and anti-CD11b 
antibodies. The percentages of CFPhigh BECs are shown. (C) The difference in mean 
fluorescence intensity (ΔMFI) values of CFP between LPS-stimulated and non-stimulated 
mice, as shown in (B). Values are the mean ± SEM from three independent experiments. (D) 
Flow cytometric analysis of spleen 3 days after injection of PBS (control, upper panels) or 
LPS (lower panels). (E) The difference in mean fluorescence intensity (ΔMFI) values of CFP 
between LPS-stimulated and non-stimulated mice as shown in (D). Values are the mean ± 
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SI Materials and Methods 
 
Generation of IL-15-CFP Knock-in Mice 
The targeting vector for IL-15-CFP knock-in mice was generated as follows. A diphtheria 
toxin A cassette was subcloned in the pBluescript KS(+) vector (pBS-DTA). A 1977-bp 
genomic DNA fragment of 3’ IL-15 region after third IL-15 exon was amplified by PCR and 
subcloned in the pBS-DTA vector (pBS-3’IL15-DTA). The enhanced CFP cassette and 
neomycin resistance gene cassette flanked by two loxP sites (LNL) were amplified by PCR 
and inserted into the pBS-3’IL15-DTA vector (pBS-CFP-LNL-3’IL15-DTA). A 7999-bp
genomic DNA fragment of the 5’IL-15 region upstream of the initiation codon in the third 
IL-15 exon was amplified by PCR and subcloned into the pBS-CFP-LNL-3’IL15-DTA vector 
(pBS-5’IL15-CFP-LNL-3’IL15-DTA) (Fig. S1A). The linearized targeting vector was 
introduced into the KY1.1 embryonic stem cell line derived from a C57BL/6J x 
129S6/SvEvTac mouse embryo (a gift of Dr. Junji Takeda of Osaka University). Homologous 
recombinants were screened by PCR and confirmed by Southern blot analysis with a 3’ probe 
(Fig. S1B). Targeted ES clones were microinjected into ICR 8-cell embryos. Chimeric mice 
were bred with CAG-Cre Tg mice to delete the neomycin cassette. Resultant mice containing 
the enhanced CFP gene within the endogenous IL-15 locus were backcrossed to C57BL/6 
mice at least for six generations. 
 
Multi-photon Tissue Imaging 
Intravital imaging of mouse calvaria bone was realized as described previously (1, 2). In brief, 
the frontoparietal regions of the calvaria of anaesthetized mice were exposed and fixed on a 
customized microscope stage. The bone marrow cavity was observed using a multi-photon 
imaging system composed of a multi-photon upright microscope (A1-MP; Nikon) equipped 
with a 25× water immersion objective (APO, N.A. 1.1; Nikon). Sample excitation was 
provided by a Chameleon Vision II Ti:Sapphire laser (Coherent) tuned at 820 nm and emitted 
fluorescence was collected using a GaAsP multi-detector unit (Nikon). eCFP- and 
eGFP-expressing cells were detected through a bandpass emission filter at 483/32 nm and 
525/50 nm, respectively, and discriminated from second harmonic generation (SHG) signals 
(representing bone tissue) by a bandpass emission filter at 414/46 nm. Blood vessels were 
visualized by injecting non-functionalized eFluor 650 nanocrystals (detected using a 593/40 
nm bandpass filter; eBioscience) i.v. immediately before imaging. Image stacks were 
collected at 2 µm vertical step size at a depth of 100–150 µm below the skull bone surface. 
  2 
Multi-photon imaging of thymus was performed on explanted tissues with the multi-photon 
inverted microscope as described for calvaria. Raw imaging data was processed with 
NIS-Elements software (Nikon) and analyzed using Imaris software (Bitplane) with a 
Gaussian filter for noise reduction.  
 
Antibodies 
The following fluorescent dye- or biotin-conjugated antibodies were used: anti-GFP, Alexa 
Fluor 488-anti-GFP, Alexa Fluor 546-anti-rabbit IgG, and streptavidin-Alexa Fluor 488 
(BioLegend); allophycocyanin (APC)-Cy7-anti-CD45, APC-Cy7-anti-CD11c, 
APC-Cy7-anti-CD11b, Alexa Fluor 647-anti-Ly51, phycoerythrin (PE)-anti-EpCAM, Pacific 
Blue-anti-MHC-II, APC-anti-CD31, Brilliant Violet 421-anti-CD31, APC-anti-CD140b 
(PDGFRβ), PE-Cy7-anti-Sca-1, biotin-anti-Podoplanin (gp38), and APC-anti-CD3 
(Invitrogen); eFluor 450-anti-CD8, APC-Cy7-anti-B220, PE-anti-CD11c, fluorescein 
isothiocyanate (FITC)-anti-F4/80, biotin-anti-rat IgG, and PE- or APC-streptavidin 
(eBioscience); and FITC-anti-CD31, APC-anti-CD11c, and APC-anti-CD11b (BD 
Pharmingen). Biotin-anti-VCAM-1 was a gift of Dr. Tatsuo Kina at Kyoto University. 
  3 
SI references 
 
1. Ishii M, et al. (2009) Sphingosine-1-phosphate mobilizes osteoclast precursors and 
regulates bone homeostasis. Nature 458(7237):524-528. 
2. Ishii M, Kikuta J, Shimazu Y, Meier-Schellersheim M, Germain RN (2010) 
Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone 
remodeling in vivo. J Exp Med 207(13):2793-2798. 
  4 
Supplemental Figure Legends 
 
Figure S1. Generation of IL-15-CFP knock-in mice. 
(A) Targeting strategy for the IL-15-CFP knock-in allele. Boxes indicate exons and cDNAs. 
ATG indicates the translation initiation codon. Triangles indicate loxP sequences. Horizontal 
bars indicate the probe. The neomycin resistance gene cassette was excised by Cre 
recombination. (B) Genomic DNA from targeted ES cells was digested with EcoRI and 
analyzed by Southern blot analysis with the 3’ probe shown in A. Wild-type (WT) and 
targeted allele (KI) samples gave rise to 9.3- and 7.0-kb EcoRI fragments, respectively. 
 
Figure S2. IL-15 expression in thymus and bone marrow. 
(A) Multi-photon fluorescence in vivo images of the IL-15-CFP knock-in thymus with 
CFP-labeled cells (left, turquoise) and collagen-fibers visualized by second harmonic 
generation (SHG) signals (right, dark blue). (B) Immunohistochemical analysis to detect 
IL-15 expression in DCs and macrophages of IL-15-CFP knock-in thymus (arrowheads). DCs 
and macrophages were stained with anti-CD11c (blue) and anti-CD11b (blue) antibodies. 
Scale bar, 50 µm. (C) Multi-photon fluorescence in vivo images of the bone marrow with 
CFP-labeled cells (left, turquoise blue) and the bone-matrix visualized by SHG-signals (right, 
dark blue) and blood vessels stained with nanocrystals (right, purple). Data represent two 
independent experiments with similar results. Scale bar, 40 µm. (D) Multi-photon 
fluorescence in vivo images of the IL-15-CFP/IL-7-GFP double knock-in bone marrow with 
CFP-labeled cells (left, turquoise blue), GFP-labeled cells (middle, green), and the 
bone-matrix visualized by SHG-signals (right, dark blue) and blood vessels stained with 
nanocrystals (right, purple). Data represent two independent experiments with similar results. 
Scale bar, 40 µm. 
 
Figure S3. IL-15 expression in hematopoietic subsets of lymph nodes and spleen. 
IL-15 expression in lymph nodes and spleen of 6- to 10-week-old IL-15-CFP knock-in mice 
(IL-15CFP/+) and control wild-type littermates (WT). CFP signals were detected with anti-GFP 
antibody. (A) Immunohistochemical analysis of DCs in lymph nodes (arrowheads). DCs were 
stained with anti-CD11c (blue) antibody. Scale bar, 50 µm. (B) Immunohistochemical 
analysis of macrophages in lymph nodes (arrowheads). Macrophages were stained with 
anti-CD11b (blue) antibody. Triple stained (red, green and blue overlap) cells appear white. 
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Scale bar, 50 µm. (C) Separation of DC subsets. (D) IL-15 expression in CD8+ and CD8 
conventional DCs (cDCs, CD11c+B220) and plasmacytoid DCs (pDCs, CD11c+B220+). Data 
represent three independent experiments with similar results. 
 
Figure S4. IL-15 expression in lymph node stromal cells during aging. 
Single cells were isolated from axillary, cervical, and inguinal lymph nodes of 1-, 3- and 
10-month-old IL-15-CFP knock-in mice (IL-15CFP/+) and control wild-type littermates (WT). 
Percentages of CFPhigh stromal cells are shown. Values are the mean ± SEM of three 
independent experiments. 
 
Figure S5. IL-15 induction in DC subsets after lipopolysaccharide (LPS) administration. 
(A) Separation of DC subsets. (B) IL-15 expression in DC subsets from 6- and 10-week-old 
IL-15-CFP knock-in mice and control wild-type littermates (WT) 3 days after injection of 
PBS (control, upper panels) or LPS (lower panels). (C) The difference in mean fluorescence 
intensity (ΔMFI) values of CFP between LPS-stimulated and non-stimulated mice as shown 
in (B). Values are the mean ± SEM of three independent experiments. 
 
Figure S6. Elimination of hematopoietic cells in flow cytometric analysis. 
(A) CD45 expression in hematopoietic subsets. Flow cytometric analysis of spleen cells 3 
days after injection of PBS or LPS. (B) CD45CD11bCD11c gated stromal cell fractions in 
lymph nodes and spleen. Data represent at least three independent experiments with similar 
results. 
 
Figure S7. IL-15 expression in heart and liver. 
IL-15 expression in heart and liver of 6- to 12-week-old IL-15-CFP knock-in mice. 
(IL-15CFP/+) and control wild-type littermates (WT). CFP signals were detected with anti-GFP 
antibody. (A) Immunohistochemical analysis of heart. Endothelial cells were stained with 
anti-CD31 antibody. CFP+CD31+ cells (blue and green overlap) appear turquoise blue. (B) 
Immunohistochemical analysis of liver. Macrophages and endothelial cells were stained with 
anti-F4/80 and anti-CD31 antibodies, respectively. (C) Immunohistochemical analysis of liver 
3 days after LPS injection. CFP+ macrophages (red and green overlap) appear yellow color. 
Data represent two independent experiments with similar results. Scale bar, 50 µm. 
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Supplemental Table 
 
Table S1. IL-15- and IL-7-expressing stromal cells in primary and secondary lymphoid 
organs 
 
Organs IL-15-expressing cell IL-7-expressing cell 
Thymus MHC-IIhigh mTEC, BEC, Pericyte* mTEC, cTEC 








Lymph node BEC, FRC*, DNSC* LEC, FRC* 
Spleen VCAM-1+ stromal cell* FRC* 
Intestine BEC, IEC* LEC, IEC* 
 































Targeting vector ECFP Neo 





CFP   SHG






  CFP CD11b CD31 !CD31 !


















A! CFP ! CD11c ! CFP CD11c CD31 !CD31 !

























FRC DNSC LEC BEC 

























































Spleen!B! Lymph node! Control! LPS!
Figure S7 
IL-15CFP/+  + LPS 
IL-15CFP/+ WT 
CFP F4/80 CD31! CFP F4/80 CD31!
CFP! F4/80! CFP F4/80 CD31!
A B WT 
CFP CD31! CFP CD31!CFP!
C 
IL-15CFP/+ 
